¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"renal infarction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • renal agenesis
    ÄáÆÏ¹«¹ß»ý, ½ÅÀ幫¹ß»ý
  • renal aminoaciduria
    ÄáÆÏ¾Æ¹Ì³ë»ê´¢, ½ÅÀ徯¹Ì³ë»ê´¢
  • renal anasarca
    ½ÅÀ强Àü½ÅºÎÁ¾
  • renal anuria
    ÄáÆÏ¹«´¢, ½ÅÀ强¹«´¢
  • renal aplasia
    ÄáÆÏ¹«Çü¼º, ½ÅÀ幫Çü¼º
  • renal apoplexy
    ÄáÆÏµÈÃâÇ÷, ½ÅÀåÁ¹Áß
  • renal arteriogram
    ÄáÆÏµ¿¸ÆÁ¶¿µ»ó, ½Å(Àå)µ¿¸ÆÁ¶¿µ»ó
  • renal arteriovenous fistula
    ÄáÆÏµ¿Á¤¸Æ»û±æ, ½ÅÀ嵿Á¤¸Æ·ç
  • renal artery
    ÄáÆÏµ¿¸Æ, ½ÅÀ嵿¸Æ
  • renal autotransplantation
    ÄáÆÏÀÚ°¡À̽Ä, ½ÅÀåÀÚ°¡À̽Ä
  • renal biopsy
    ÄáÆÏ»ý°Ë, ½ÅÀå»ý°Ë
  • renal calcinosis
    ÄáÆÏ¼®È¸Áõ, ½ÅÀ弮ȸÁõ
  • renal calculus
    ÄáÆÏµ¹, ½ÅÀå°á¼®
  • renal calyx
    ÄáÆÏÀÜ, ½Å¹è
  • renal cancer
    ÄáÆÏ¾Ï, ½ÅÀå¾Ï
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • renal tuberculosis
    ÄáÆÏ°áÇÙ, ½ÅÀå°áÇÙ
  • renal transplantation
    ÄáÆÏÀ̽Ä, ½ÅÀåÀ̽Ä
  • renal function test
    ÄáÆÏ±â´É°Ë»ç, ½ÅÀå±â´É°Ë»ç
  • renal vein thrombosis
    ÄáÆÏÁ¤¸ÆÇ÷ÀüÁõ, ½ÅÀåÁ¤¸ÆÇ÷ÀüÁõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • crossed renal ectopia
    ¾ù°¥¸°ÄáÆÏµý°÷Áõ
  • cystic renal dysplasia
    ³¶¼ºÄáÆÏÇü¼ºÀÌ»ó, ³¶¼º½ÅÀåÇü¼ºÀÌ»ó
  • cystic renal medulla
    ÁÖ¸Ó´ÏÄáÆÏ¼ÓÁú, ÁָӴϽżöÁú
  • renal calcinosis
    (¢¡nephrocalcinosis) ÄáÆÏ¼®È¸Áõ
  • renal calculus
    ÄáÆÏµ¹, ½ÅÀå¼®
  • renal calyx
    ÄáÆÏÀÜ, ½Å¹è
  • renal cast
    (¢¡urinary cast) ¿ä¿øÁÖ
  • renal column
    ÄáÆÏ±âµÕ, ½ÅÀå±âµÕ
  • renal crisis
    ÄáÆÏ±ÞÅëÁõ
  • renal vein catheterization
    ÄáÆÏÁ¤¸Æµµ°ü»ðÀÔ
  • renal disease
    ÄáÆÏº´, ½ÅÀ庴
  • renal disorder
    ÄáÆÏÀå¾Ö, ½ÅÀåÀå¾Ö
  • renal vascular disorder
    ÄáÆÏÇ÷°üÀå¾Ö, ½ÅÀåÇ÷°üÀå¾Ö
  • effective renal blood flow
    À¯È¿ÄáÆÏÇ÷·ù·®
  • effective renal plasma flow
    À¯È¿ÄáÆÏÇ÷Àå·ù·®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hemorrhagic fever with renal syndrome, HFRS
    ½ÅÁõÈÄ ÃâÇ÷¿­
  • hepato renal echo contrast
    °£ ½ÅÀå ¿¡ÄÚ ´ëÁ¶
  • hepato-renal echo contrast
    °£-½ÅÀå (ÊÜ-ãìíô) ¿¡ÄÚ ´ëÁ¶ (ÓßðÎ), °£-½ÅÀå (ÊÜ-ãì
  • heteroplasia (renal cartilage)
    ´Ù¸¥Á¶Á÷Çü¼º (ÄáÆÏ¿¬°ñ)
  • post-renal azotemia
    ½ÅÈļº(ãìý­àõ) Áú¼ÒÇ÷(Áõ)
  • radioisotope renal clearance method
    ¹æ»ç¼º µ¿À§¿ø¼Ò¼º ½ÅÁ¦°ÅÀ²ÃøÁ¤¹ý(¡­ê« áÈàõãìð¶ËÛëÒö´ïÒÛö).
  • radioisotope renal excretion test
    ¹æ»ç¼º µ¿À§¿ø¼Ò¼º ½Å¹è¼³½ÃÇè(¡­ãìÛÉàÜãË úÐ).
  • radionuclide renal scan
    ¹æ»ç¼ºÇÙÁ¾ ½ÅÁÖ»ç
  • renal
    ÄáÆÏÀÇ, ½ÅÀÇ, ½Å¼ºÀÇ.(ÇØºÎ)½ÅÀå(ãìíô)ÀÇ.
  • renal
    ½Å(ãì)ÀÇ,½ÅÀå(ãìíô)ÀÇ,½Å¼º(ãìàõ)ÀÇ, ÄáÆÏ(ÀÇ)
  • renal ablation glomerulosclerosis
    ½ÅÀýÁ¦»ç±¸Ã¼°æÈ­Áõ(ãìï·ð¶ÞêϹô÷Ìãûùñø)
  • renal abscess
    ½ÅÇÇÁú³ó¾ç
  • renal abscess
    ½Å³ó¾ç(ãìÒÛåË)
  • renal acidosis
    ½Å¼º»êÁõ.
  • renal acidosis
    ½Å¼º»êÁõ(ãìàõß«ñø)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • myocardial infarction,transmural
    ÀüÃþ°æ»öÁõ(îïöµÌÛßáñø)
  • myocardial infarction,ventricular aneurysm
    ½É½Ç·ù(ãýãø×µ)
  • myocardial infarction,wavy fibers
    ÆÄµ¿Çü ¼¶À¯(÷îÔÑúþ àéë«)
  • old myocardial infarction
    Áø±¸¼º ½É±Ù°æ»ö(Áõ)(òçÏÁàõãýÐÉÌãßáñø),°ú°Å½É±Ù°æ»ö.
  • old myocardial infarction
    Áø±¸¼º ½É±Ù°æ»ö(Áõ)(òçÏÁàõãýÐÉÌãßáñø).
  • placental infarction
    Źݰæ»ö(¡­ÌÛßá).
  • placental infarction
    Źݰæ»ö(÷ÃÚïÌÛßá)
  • post-infarction syndrome
    »öÀüÈÄ ÁõÈıº
  • posterior (myocardial) infarction
    (½ÉÀå)Èĺ®°æ»öÁõ(ãýíôý­ÛúÌÛßáñø).
  • posterior (myocardial) infarction
    (½ÉÀå)Èĺ®°æ»öÁõ((ãýíô)ý­ÛúÌÛßáñø)
  • postmyocardial infarction syndrome
    ½É±Ù°æ»öÈÄÁõÈıº.
  • postmyocardial infarction syndrome
    ½É±Ù°æ»öÈÄÁõÈıº(ãýÐÉÌÛßáý­ñøý¦ÏØ)
  • pulmonary infarction
    Æó°æ»ö
  • pulmonary infarction
    Æó°æ»öÁõ(øËÌÛßáñø)
  • q wave,in myocardial infarction
    ½É±Ù°æ»öÀÇ (QÆÄ)(ãýÐÉÌÛßá¡­)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Renal lobes
    ÄáÆÏ¿±
    [¿¾ ¿ë¾î] ½Å¿±
  • Renal papilla
    ÄáÆÏÀ¯µÎ
    [¿¾ ¿ë¾î] ½ÅÀ¯µÎ
  • Renal papillae
    ÄáÆÏÀ¯µÎ
    [¿¾ ¿ë¾î] ½ÅÀ¯µÎ
  • Renal impression
    ÄáÆÏÀÚ±¹
    [¿¾ ¿ë¾î] ½Å¾ÐÈç
  • Renal veins
    ÄáÆÏÁ¤¸Æ
    [¿¾ ¿ë¾î] ½ÅÁ¤¸Æ
  • Renal tissue (Nephroblastoma)
    ÄáÆÏÁ¶Á÷ (ÄáÆÏ¸ð¼¼Æ÷Á¾)
    [¿¾ ¿ë¾î] ½ÅÁ¶Á÷
  • Renal pyramid
    ÄáÆÏÇǶó¹Ô
    [¿¾ ¿ë¾î] ½ÅÃßü
  • Renal pyramids
    ÄáÆÏÇǶó¹Ô
    [¿¾ ¿ë¾î] ½ÅÃßü
  • Renal capsule
    ÄáÆÏÇǸ·
    [¿¾ ¿ë¾î] ½ÅÇǸ·
  • Renal blood vessel
    ÄáÆÏÇ÷°ü
    [¿¾ ¿ë¾î] ½ÅÀåÇ÷°ü
  • Major renal calices
    Å«(ÄáÆÏ)¼úÀÜ
    [¿¾ ¿ë¾î] ´ë½Å¹è
  • Base of renal pyramid
    ÇǶó¹Ô¹Ù´Ú
    [¿¾ ¿ë¾î] ÃßüÀú
  • Arcuate renal tubule
    Ȱ²Ã¼¼°ü
    [¿¾ ¿ë¾î] ±Ã»ó¿ä¼¼°ü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
SRF severe renal failure; skin reactive factor; somatotropin-releasing factor; split renal function; sub...
AMI Acute Myocardial Infarction
  - Complications(Cx)
    1. Early ...
CI   1) Corporate Identity
  2) Completed Infarction
  3) Cardiac I...
LI Lateral Infarction
MI   1) Mitral Insufficient
    = MR
  2) Myocardial Infa...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
SCI Silent cerebral infarction
TIMI Thombolysis in Myocardial Infarction
TIMI Thrombolysis In Myocardial Infarction trial
TAMI Thrombolysis and Angioplasty in Myocardial Infarction
AIMI acute inferior myocardial infarction
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • renal artery stenosis
    ½Åµ¿¸Æ ÇùÂø
  • renal atheroembolic disease
    ½ÅÁ×»ó Àü»öº´, ½ÅÁ×Á¾ »öÀüº´
  • renal autonomic plexus
    ½Å ÀÚÀ² ½Å°æÃÑ
  • renal azotemia
    ½Å¼º °íÁú¼Ò Ç÷Áõ
  • renal bench surgery
    ü¿Ü ½Å¼ö¼ú
  • renal bleeding
    ½Å ÃâÇ÷
  • renal blood flow
    ½Å Ç÷·ù·®
  • renal calcinosis
    ½Å ¼®È¸È­Áõ
    µ¿ÀǾî=ne
  • renal calculi
    ½Å °á¼®
  • renal calyces
    ½Å¹è
  • renal cancer
    ½Å ¾Ï
  • renal capsular flap
    ½Å ÇǸ·Æí
  • renal capsulotomy
    ½ÅÇǸ· Àý°³, ½ÅÇǸ· Àý°³¼ú
  • renal carcinosarcoma
    ½Å¾Ï À°Á¾
  • renal causes of hyperkalemia
    ½Å¼º °íÄ®·ýÇ÷Áõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
capsular branches of renal artery <anatomy, artery> Branches arising from the renal artery outside of the kidney that are distributed to the renal capsule.
Synonym: rami capsulares arteriae renalis.
(05 Mar 2000)
captopril renal scan <radiology> In a kidney with a lesion in the afferent arteriole (e.g. Atherosclerotic plaque), reflex constriction of the efferent arteriole occurs through angiotensin system thus maintaining renal perfusion. ACE inhibition prevents constriction of efferent arteriole. Therefore, perfusion is decreased to a kidney with afferent lesions and the renal scan to looks WORSE. Bottom line: renal scans appear WORSE with captopril administration if there is a lesion in the afferent arteriole. See: renal artery stenosis
(12 Dec 1998)
carcinoma, renal cell Carcinoma of the renal parenchyma usually occurring in middle age or later and composed of tubular cells in varying arrangements. It was first described in 1826. Possible causal factors are environmental, hormonal, cellular, and genetic. Smoking is a definite risk factor and obesity is associated with increased risk. Renal cell carcinoma accounts for approximately 3% of adult cancer; the male-female ratio is 2:1. It is more common among urban residents than rural.
(12 Dec 1998)
renal <anatomy> Pertaining to the kidney, nephric.
(18 Nov 1997)
renal adenocarcinoma <radiology> Hypernephroma, renal cell carcinoma, arises from proximal collecting tubule, 10% bilateral adenocarcinoma types: papillary, alveolar, onchocytoma vascularity, 85% hypervascular (require pre-op embolization), 10% hypovascular (usually papillary type), 5% avascular associated with: tuberous sclerosis, von Hippel-Lindau syndrome see also: staging
(12 Dec 1998)
renal adenocarcinoma: staging <radiology> Typical presentation: Haematuria . . . . . 70% Fever . . . . . . . 16% Pain . . . . . . . . 50% Polycythemia . . . . 3% Palpable mass . . . 20% Anatomic staging (TNM): T1 Small tumour, kidney not enlarged T2 Large tumour, contained within renal capsule T3 Extension into perinephric fat or renal vein T4 Invasion of adjacent organs
(12 Dec 1998)
renal adenocarcinoma: vascularity <radiology> 85% hypervascular (require pre-op embolization), 10% hypovascular (usually the papillary type), 5% avascular also: 10% are bilateral
(12 Dec 1998)
renal agenesis <radiology> Associated with, duplicated vagina and/or uterus (mullerian duct anomaly), seminal vesicle cysts
(12 Dec 1998)
renal agents Drugs used for their effects on the kidneys' regulation of body fluid composition and volume. The most commonly used are the diuretics. Also included are drugs used for their antidiuretic and uricosuric actions, for their effects on the kidneys' clearance of other drugs, and for diagnosis of renal function.
(12 Dec 1998)
renal amyloidosis Renal deposits of amyloid, especially in glomerular capillary walls, which may cause albuminuria and the nephrotic syndrome.
Synonym: amyloid nephrosis.
(05 Mar 2000)
renal artery <anatomy, artery> A branch of the abdominal aorta which supplies the kidneys, adrenal glands and ureters.
(12 Dec 1998)
renal artery obstruction Narrowing or occlusion of the renal arteries. It is due usually to atherosclerosis, fibromuscular dysplasia, thrombosis, embolism, or external pressure. It may result in renovascular hypertension.
(12 Dec 1998)
renal artery stenosis <cardiology, nephrology> A narrowing of the renal artery or one of its main branches accounts for 2 to 5% of cases of hypertension.
(27 Sep 1997)
renal ballottement A manoeuvre in which the kidney is moved by pressure from behind, allowing it to be felt between the hands and its size, shape, and mobility determined.
(05 Mar 2000)
renal blood flow, effective The amount of blood flowing to the parts of the kidney that are involved with the production of constituents of urine. It is that portion of the total renal blood flow that perfuses functional renal tissue (e.g., the glomeruli). It should be differentiated from renal plasma flow, effective which is based on the amount of plasma rather than on total renal blood.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á